ArticleHeart rhythm O22026
Pulsed-field vs radiofrequency ablation for posterior wall isolation in persistent atrial fibrillation: A propensity-matched outcome analysis.
Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Left atrial posterior wall isolation (LAPWI) is increasingly used as an adjunct to pulmonary vein isolation in patients with persistent atrial fibrillation (PerAF) despite the absence of strong evidence, but the optimal ablation modality remains uncertain. Objective: Our study focuses on procedural differences between pulsed-field ablation (PFA) and radiofrequency (RF) ablation when LAPWI is performed, rather than on the efficacy of LAPWI itself. PFA may offer advantages over RF ablation owing to its nonthermal mechanism and improved tissue selectivity. Methods: In this single-center study, 92 patients with PerAF and posterior low-voltage substrate identified using high-density mapping were treated with either PFA (n = 46) or RF ablation (n = 46) for pulmonary vein isolation plus LAPWI. Remapping was performed to confirm complete electrical isolation. Groups were 1:1 propensity score matched for analysis. Results: The primary end point was freedom from any sustained atrial arrhythmia (>30 seconds) at 12-month follow-up, assessed using structured Holter electrocardiogram monitoring at 3, 6, and 12 months. Complete LAPWI was achieved in 100% of PFA and 95.7% of RF ablation patients. Procedure time was significantly shorter with PFA (68.2 minutes [44-91] vs 86.8 minutes [58-118]; Conclusion: In patients with PerAF and posterior low-voltage substrate, PFA and RF ablation yielded similar arrhythmia-free survival at 1 year. PFA was associated with shorter procedure times and high rates of posterior wall isolation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.